Immune Response Completed Phase Trials for Influenza A virus A/Texas/50/2012 X-223 (H3N2) antigen (propiolactone inactivated) (DB11045)

IndicationStatusPhase
DBCOND0034832 (Immune Response)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02872311Open-Label Influenza Vaccine EvaluationBasic Science
NCT00902278Immune Responses Induced by Different Licensed Influenza VaccinesBasic Science